Li-Fraumeni syndrome: genes and variants
Li-Fraumeni syndrome is linked to 2 analyzed proteins (TP53 and CHEK2). 188 DNA variants are known to cause it; 865 more are uncertain, and 55 of those already look disease-causing on computable evidence.
Last updated 2026-09-30. Research information, not medical advice.
Also known as: Li-Fraumeni syndrome 1
Genes linked to Li-Fraumeni syndrome
TP53: Cellular tumor antigen p53
It coordinates transcriptional responses to DNA damage and other cellular stresses, promoting cell-cycle arrest, senescence, DNA repair, or apoptosis when appropriate. Loss of this tumor-suppressive control is one of the most common events in cancer, while germline pathogenic variants cause Li-Fraumeni syndrome.
188 disease-causing and 857 uncertain variants in TP53 are linked to Li-Fraumeni syndrome.
CHEK2: Serine/threonine-protein kinase Chk2
It propagates DNA-damage checkpoint signals to proteins controlling cell-cycle arrest, repair, and apoptosis. Germline loss-of-function variants confer moderate cancer susceptibility, especially for breast cancer, while risk estimates depend on the specific allele and family context.
0 disease-causing and 7 uncertain variants in CHEK2 are linked to Li-Fraumeni syndrome.
Weakly linked (only a few uncertain records): CDKN2A.
Where Li-Fraumeni syndrome variants cluster
- TP53 DNA binding (positions 102–292): 167 of 179 disease-causing changes, 1.9× more than its size predicts.
Known disease-causing variants in Li-Fraumeni syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TP53 A138V | 138 | DNA binding | Disease-causing (★★★) |
| TP53 R158L | 158 | DNA binding | Disease-causing (★★★) |
| TP53 Y163C | 163 | DNA binding | Disease-causing (★★★) |
| TP53 V173M | 173 | DNA binding | Disease-causing (★★★) |
| TP53 R175H | 175 | DNA binding | Disease-causing (★★★) |
| TP53 R175G | 175 | DNA binding | Disease-causing (★★★) |
| TP53 H179Q | 179 | DNA binding | Disease-causing (★★★) |
| TP53 R181C | 181 | DNA binding | Disease-causing (★★★) |
| TP53 H193P | 193 | DNA binding | Disease-causing (★★★) |
| TP53 L194R | 194 | DNA binding | Disease-causing (★★★) |
| TP53 H214R | 214 | DNA binding | Disease-causing (★★★) |
| TP53 Y220C | 220 | DNA binding | Disease-causing (★★★) |
| TP53 M237I | 237 | DNA binding | Disease-causing (★★★) |
| TP53 C238G | 238 | DNA binding | Disease-causing (★★★) |
| TP53 G245S | 245 | DNA binding | Disease-causing (★★★) |
| TP53 R248W | 248 | DNA binding | Disease-causing (★★★) |
| TP53 R248Q | 248 | DNA binding | Disease-causing (★★★) |
| TP53 I254T | 254 | DNA binding | Disease-causing (★★★) |
| TP53 I254N | 254 | DNA binding | Disease-causing (★★★) |
| TP53 V272M | 272 | DNA binding | Disease-causing (★★★) |
| TP53 R273H | 273 | DNA binding | Disease-causing (★★★) |
| TP53 R280S | 280 | DNA binding | Disease-causing (★★★) |
| TP53 L344P | 344 | Nuclear export signal | Disease-causing (★★★) |
| TP53 L111Q | 111 | DNA binding | Disease-causing (★★★) |
| TP53 L111R | 111 | DNA binding | Disease-causing (★★★) |
| TP53 S127P | 127 | DNA binding | Disease-causing (★★★) |
| TP53 S127T | 127 | DNA binding | Disease-causing (★★★) |
| TP53 S127C | 127 | DNA binding | Disease-causing (★★★) |
| TP53 C135G | 135 | DNA binding | Disease-causing (★★★) |
| TP53 A138P | 138 | DNA binding | Disease-causing (★★★) |
| TP53 V143A | 143 | DNA binding | Disease-causing (★★★) |
| TP53 Y163H | 163 | DNA binding | Disease-causing (★★★) |
| TP53 R175L | 175 | DNA binding | Disease-causing (★★★) |
| TP53 H214L | 214 | DNA binding | Disease-causing (★★★) |
| TP53 R248L | 248 | DNA binding | Disease-causing (★★★) |
| TP53 R337C | 337 | Oligomerization | Disease-causing (★★★) |
| TP53 L344R | 344 | Nuclear export signal | Disease-causing (★★★) |
| TP53 P151L | 151 | DNA binding | Disease-causing (★★★) |
| TP53 P152L | 152 | DNA binding | Disease-causing (★★★) |
| TP53 K164E | 164 | DNA binding | Disease-causing (★★★) |
| TP53 H178D | 178 | DNA binding | Disease-causing (★★★) |
| TP53 P190L | 190 | DNA binding | Disease-causing (★★★) |
| TP53 R337P | 337 | Oligomerization | Disease-causing (★★★) |
| TP53 R337L | 337 | Oligomerization | Disease-causing (★★★) |
| TP53 R110G | 110 | DNA binding | Disease-causing (★★★) |
| TP53 R110P | 110 | DNA binding | Disease-causing (★★★) |
| TP53 K132N | 132 | DNA binding | Disease-causing (★★★) |
| TP53 E180K | 180 | DNA binding | Disease-causing (★★★) |
| TP53 V197M | 197 | DNA binding | Disease-causing (★★★) |
| TP53 C277G | 277 | DNA binding | Disease-causing (★★★) |
| TP53 R283P | 283 | DNA binding | Disease-causing (★★★) |
| TP53 R337S | 337 | Oligomerization | Disease-causing (★★★) |
| TP53 R337G | 337 | Oligomerization | Disease-causing (★★★) |
| TP53 A347D | 347 | Nuclear export signal | Disease-causing (★★★) |
| TP53 S106R | 106 | DNA binding | Disease-causing (★★★) |
| TP53 R342P | 342 | Nuclear export signal | Disease-causing (★★★) |
| TP53 R110L | 110 | DNA binding | Disease-causing (★★★) |
| TP53 L111P | 111 | DNA binding | Disease-causing (★★★) |
| TP53 S127Y | 127 | DNA binding | Disease-causing (★★★) |
| TP53 R158P | 158 | DNA binding | Disease-causing (★★★) |
Showing 60 of 188.
Uncertain variants in Li-Fraumeni syndrome that look disease-causing
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| TP53 T125S | 125 | DNA binding | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; T125K at the same position is pathogenic; REVEL 0.963 |
| TP53 C275S | 275 | DNA binding | Conflicting reports (★) | +6: 11 other pathogenic changes within 3 positions; C275F at the same position is pathogenic; REVEL 0.982 |
| TP53 P278R | 278 | DNA binding | Conflicting reports (★) | +6: 13 other pathogenic changes within 3 positions; P278T at the same position is pathogenic; REVEL 0.951 |
| TP53 A276D | 276 | DNA binding | Conflicting reports (★) | +6: 9 other pathogenic changes within 3 positions; A276G at the same position is pathogenic; REVEL 0.951 |
| TP53 C242F | 242 | DNA binding | Conflicting reports (★) | +6: 15 other pathogenic changes within 3 positions; C242W at the same position is pathogenic; REVEL 0.977 |
| TP53 G334R | 334 | Oligomerization | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; G334W at the same position is pathogenic; REVEL 0.957 |
| TP53 T125M | 125 | DNA binding | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; T125K at the same position is pathogenic; REVEL 0.925 |
| TP53 C277F | 277 | DNA binding | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; C277G at the same position is pathogenic; REVEL 0.932 |
| TP53 Y126C | 126 | DNA binding | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; Y126D at the same position is pathogenic; REVEL 0.981 |
| TP53 A276P | 276 | DNA binding | Conflicting reports (★) | +6: 9 other pathogenic changes within 3 positions; A276G at the same position is pathogenic; REVEL 0.949 |
| TP53 C135Y | 135 | DNA binding | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; C135G at the same position is pathogenic; REVEL 0.955 |
| TP53 K132E | 132 | DNA binding | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; K132N at the same position is pathogenic; REVEL 0.968 |
| TP53 Y126N | 126 | DNA binding | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; Y126D at the same position is pathogenic; REVEL 0.965 |
| TP53 A161D | 161 | DNA binding | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; A161T at the same position is pathogenic; REVEL 0.908 |
| TP53 C275G | 275 | DNA binding | Conflicting reports (★) | +6: 11 other pathogenic changes within 3 positions; C275F at the same position is pathogenic; REVEL 0.957 |
| TP53 E258G | 258 | DNA binding | Conflicting reports (★) | +6: E258K at the same position is pathogenic; REVEL 0.952 |
| TP53 P177S | 177 | DNA binding | Conflicting reports (★) | +6: 10 other pathogenic changes within 3 positions; P177R at the same position is pathogenic; REVEL 0.877 |
| TP53 R249G | 249 | DNA binding | Conflicting reports (★) | +6: 12 other pathogenic changes within 3 positions; R249S at the same position is pathogenic; REVEL 0.888 |
| TP53 C176R | 176 | DNA binding | Conflicting reports (★) | +6: 12 other pathogenic changes within 3 positions; C176F at the same position is pathogenic; REVEL 0.940 |
| TP53 H179N | 179 | DNA binding | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; H179R at the same position is pathogenic; REVEL 0.902 |
| TP53 H178P | 178 | DNA binding | Conflicting reports (★) | +6: 11 other pathogenic changes within 3 positions; H178D at the same position is pathogenic; REVEL 0.918 |
| TP53 N239T | 239 | DNA binding | Conflicting reports (★) | +6: 18 other pathogenic changes within 3 positions; N239S at the same position is pathogenic; REVEL 0.935 |
| TP53 P177L | 177 | DNA binding | Conflicting reports (★) | +6: 10 other pathogenic changes within 3 positions; P177R at the same position is pathogenic; REVEL 0.865 |
| TP53 E286G | 286 | DNA binding | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; E286A at the same position is pathogenic; REVEL 0.913 |
| TP53 G105D | 105 | DNA binding | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; G105R at the same position is pathogenic; REVEL 0.884 |
| TP53 S240R | 240 | DNA binding | Conflicting reports (★) | +6: 16 other pathogenic changes within 3 positions; S240G at the same position is pathogenic; REVEL 0.908 |
| TP53 M246R | 246 | DNA binding | Conflicting reports (★) | +6: 16 other pathogenic changes within 3 positions; M246K at the same position is pathogenic; REVEL 0.959 |
| TP53 P190R | 190 | DNA binding | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; P190L at the same position is pathogenic; REVEL 0.846 |
| TP53 Y220D | 220 | DNA binding | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; Y220C at the same position is pathogenic; REVEL 0.934 |
| TP53 C242G | 242 | DNA binding | Conflicting reports (★) | +6: 15 other pathogenic changes within 3 positions; C242W at the same position is pathogenic; REVEL 0.963 |
| TP53 F109V | 109 | DNA binding | Conflicting reports (★) | +6: 11 other pathogenic changes within 3 positions; F109I at the same position is pathogenic; REVEL 0.875 |
| TP53 R196G | 196 | DNA binding | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; R196P at the same position is pathogenic; REVEL 0.897 |
| TP53 H193L | 193 | DNA binding | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; H193N at the same position is pathogenic; REVEL 0.864 |
| TP53 M237V | 237 | DNA binding | Conflicting reports (★) | +6: 15 other pathogenic changes within 3 positions; M237K at the same position is pathogenic; REVEL 0.937 |
| TP53 A159P | 159 | DNA binding | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; A159D at the same position is pathogenic; REVEL 0.815 |
| TP53 F270L | 270 | DNA binding | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; F270S at the same position is pathogenic; REVEL 0.827 |
| TP53 G244R | 244 | DNA binding | Uncertain (★) | +6: 17 other pathogenic changes within 3 positions; G244A at the same position is pathogenic; REVEL 0.942 |
| TP53 G334E | 334 | Oligomerization | Uncertain (★★) | +6: 6 other pathogenic changes within 3 positions; G334W at the same position is pathogenic; REVEL 0.950 |
| TP53 R196Q | 196 | DNA binding | Uncertain (★★★) | +6: 8 other pathogenic changes within 3 positions; R196P at the same position is pathogenic; REVEL 0.888 |
| TP53 G105A | 105 | DNA binding | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; G105R at the same position is pathogenic; REVEL 0.905 |
Which prediction tools work for Li-Fraumeni syndrome
How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).
- MutPred2: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 95 out of 100
- ESM1b (LLR): 95 out of 100
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaGenome (regulatory): 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 90 out of 100
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 88 out of 100
- SIFT: 86 out of 100
- phyloP: 84 out of 100
- DMS / MaveDB: 57 out of 100
- AlphaGenome (splicing): 56 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Adrenocortical carcinoma, hereditary is also caused by TP53 variants; they fall in the same places as the Li-Fraumeni syndrome variants (23 disease-causing).
- Acute myeloid leukemia is also caused by TP53 variants; they fall in the same places as the Li-Fraumeni syndrome variants (6 disease-causing).
- Familial cancer of breast is also caused by TP53 variants; they fall in the same places as the Li-Fraumeni syndrome variants (5 disease-causing).
- Glioma susceptibility 1 is also caused by TP53 variants; they fall in the same places as the Li-Fraumeni syndrome variants (5 disease-causing).
- Hereditary breast ovarian cancer syndrome is also caused by TP53 variants; they fall in the same places as the Li-Fraumeni syndrome variants (5 disease-causing).
Diseases related to Li-Fraumeni syndrome
- Familial cancer of breast, also linked to CHEK2 and TP53
- Colorectal cancer, also linked to CHEK2 and TP53
- Gastric cancer, also linked to CHEK2 and TP53
- Hereditary breast ovarian cancer syndrome, also linked to CHEK2 and TP53
- Breast and/or ovarian cancer, also linked to CHEK2 and TP53
- Bone osteosarcoma, also linked to CHEK2 and TP53
- Acute myeloid leukemia, also linked to TP53
- Adrenocortical carcinoma, hereditary, also linked to TP53
- Breast-ovarian cancer, familial, susceptibility to, 1, also linked to TP53
- Hereditary nonpolyposis colon cancer, also linked to CHEK2
- Glioma susceptibility 1, also linked to TP53
- Ovarian neoplasm, also linked to TP53
Frequently asked questions
Which genes are linked to Li-Fraumeni syndrome?
In CATVariant, Li-Fraumeni syndrome is linked to 2 analyzed proteins: TP53 (Cellular tumor antigen p53) and CHEK2 (Serine/threonine-protein kinase Chk2).
How many genetic variants are linked to Li-Fraumeni syndrome?
1,147 variants: 188 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 865 are of uncertain significance or have conflicting reports.
Which uncertain variants in Li-Fraumeni syndrome look disease-causing?
55 uncertain variants reach the likely-pathogenic range of the ACMG/AMP points scale on computable evidence, for example TP53 T125S, TP53 C275S, TP53 P278R, TP53 A276D and TP53 C242F. These are leads for expert review, not diagnoses.
Which variant effect predictor works best for Li-Fraumeni syndrome?
Among tools not trained on clinical labels, AlphaMissense separates this disease's known disease-causing variants from harmless ones best (AUROC 0.95, based on 179 disease-causing and 156 harmless variants).
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center